Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783286 · ClinicalTrials.gov registry record
Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 15
- Enrollment target
NCT03783286 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 15 participants.
The verdict
NCT03783286 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the effects of clinically prescribed ivacaftor treatment on 4-24 month old children with CF and gating mutations on sleeping energy expenditure, growth status and gut health and function.
Interventions
- DRUG Ivacaftor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-02-06 |
| Est. Completion | 2021-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03783286
The ClinicalTrials.gov registry entry for NCT03783286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ivacaftor is the first listed.
NCT03783286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03783286 about?
NCT03783286 is a clinical study titled "Ivacaftor Treatment in 4 Month to 2 Year Old CF Subjects". The purpose of this research study is to determine the effects of clinically prescribed ivacaftor treatment on 4-24 month old children with CF and gating mutations on sleeping energy expenditure, growth status and gut health and function.
What is the current status of trial NCT03783286?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2019-02-06. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT03783286?
The interventions under investigation include: Ivacaftor (DRUG).
Who is sponsoring clinical trial NCT03783286?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.